These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 26220974

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Altered nutrient response of mTORC1 as a result of changes in REDD1 expression: effect of obesity vs. REDD1 deficiency.
    Williamson DL, Li Z, Tuder RM, Feinstein E, Kimball SR, Dungan CM.
    J Appl Physiol (1985); 2014 Aug 01; 117(3):246-56. PubMed ID: 24876363
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prion formation correlates with activation of translation-regulating protein 4E-BP and neuronal transcription factor Elk1.
    Allard EK, Grujic M, Fisone G, Kristensson K.
    Neurobiol Dis; 2013 Oct 01; 58():116-22. PubMed ID: 23742760
    [Abstract] [Full Text] [Related]

  • 9. mTORC1 Signaling in oocytes is dispensable for the survival of primordial follicles and for female fertility.
    Gorre N, Adhikari D, Lindkvist R, Brännström M, Liu K, Shen Y.
    PLoS One; 2014 Oct 01; 9(10):e110491. PubMed ID: 25338086
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. S6K1 alternative splicing modulates its oncogenic activity and regulates mTORC1.
    Ben-Hur V, Denichenko P, Siegfried Z, Maimon A, Krainer A, Davidson B, Karni R.
    Cell Rep; 2013 Jan 31; 3(1):103-15. PubMed ID: 23273915
    [Abstract] [Full Text] [Related]

  • 12. AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1/4E-BP1 axis.
    Mi W, Ye Q, Liu S, She QB.
    Oncotarget; 2015 Jun 10; 6(16):13962-77. PubMed ID: 25961827
    [Abstract] [Full Text] [Related]

  • 13. mTORC1 is necessary but mTORC2 and GSK3β are inhibitory for AKT3-induced axon regeneration in the central nervous system.
    Miao L, Yang L, Huang H, Liang F, Ling C, Hu Y.
    Elife; 2016 Mar 30; 5():e14908. PubMed ID: 27026523
    [Abstract] [Full Text] [Related]

  • 14. Re: mTORC1 Drives HIF-1α and VEGF-A Signalling via Multiple Mechanisms Involving 4E-BP1, S6K1 and STAT3.
    Atala A.
    J Urol; 2016 Feb 30; 195(2):524. PubMed ID: 26853037
    [No Abstract] [Full Text] [Related]

  • 15. Nutrient-induced stimulation of protein synthesis in mouse skeletal muscle is limited by the mTORC1 repressor REDD1.
    Gordon BS, Williamson DL, Lang CH, Jefferson LS, Kimball SR.
    J Nutr; 2015 Apr 30; 145(4):708-13. PubMed ID: 25716553
    [Abstract] [Full Text] [Related]

  • 16. The mTOR Substrate S6 Kinase 1 (S6K1) Is a Negative Regulator of Axon Regeneration and a Potential Drug Target for Central Nervous System Injury.
    Al-Ali H, Ding Y, Slepak T, Wu W, Sun Y, Martinez Y, Xu XM, Lemmon VP, Bixby JL.
    J Neurosci; 2017 Jul 26; 37(30):7079-7095. PubMed ID: 28626016
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Phosphatase control of 4E-BP1 phosphorylation state is central for glycolytic regulation of retinal protein synthesis.
    Gardner TW, Abcouwer SF, Losiewicz MK, Fort PE.
    Am J Physiol Endocrinol Metab; 2015 Sep 15; 309(6):E546-56. PubMed ID: 26199279
    [Abstract] [Full Text] [Related]

  • 19. Phosphorylation of ribosomal protein S6 mediates compensatory renal hypertrophy.
    Xu J, Chen J, Dong Z, Meyuhas O, Chen JK.
    Kidney Int; 2015 Mar 15; 87(3):543-56. PubMed ID: 25229342
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.